LYELL IMMUNOPHARMA INC

CUSIP: 55083R104 Class: Common Stock

ROYAL BANK OF CANADA's Holding History (CIK: 0001000275)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 19,746 Value ($000) $11 Avg Close — Range —
Q4 2024
Shares 23,539 Value ($000) $15 Avg Close — Range —
Q3 2024
Shares 16,706 Value ($000) $23 Avg Close — Range —
Q2 2024
Shares 15,115 Value ($000) $22 Avg Close — Range —
Q1 2024
Shares 4,016 Value ($000) $9 Avg Close — Range —
Q4 2023
Shares 51,090 Value ($000) $99 Avg Close — Range —
Q3 2023
Shares 29,184 Value ($000) $43 Avg Close — Range —
Q2 2023
Shares 18,104 Value ($000) $58 Avg Close — Range —
Q1 2023
Shares 9,680 Value ($000) $23 Avg Close — Range —
Q4 2022
Shares 21,519 Value ($000) $74 Avg Close — Range —
Q3 2022
Shares 2,107 Value ($000) $15 Avg Close — Range —
Q2 2022
Shares 974 Value ($000) $6 Avg Close — Range —
Q1 2022
Shares 9,114 Value ($000) $46 Avg Close — Range —
Q4 2021
Shares 5,174 Value ($000) $40 Avg Close — Range —
Q3 2021
Shares 2,813 Value ($000) $41 Avg Close — Range —